UnitedHealth Group Inc.
UnitedHealth Group Inc. demonstrates strong top-line growth and efficient cash flow generation, but recent net profit trends show a notable decline. The company maintains its position as a Mega Cap entity in the Healthcare sector.
Business Performance (CAGR)
Valuation Snapshot
Financial Health
Profitability Metrics
Cash Flow Intelligence
Intrinsic Value
PremiumEstimated Intrinsic Value & DCF Fair Value are available with Premium plans.
AI Business Verdict
UnitedHealth Group Inc. demonstrates strong revenue growth and effective cash flow generation, positioning it as a significant entity in the healthcare sector. However, the projected decline in net profit and lower profitability scores raise concerns about future earnings power and operational efficiency. The current market valuation appears to exceed its calculated intrinsic value, suggesting a cautious outlook from a pure valuation perspective.
- Robust revenue growth CAGR of 10.32% over the years.
- Strong operating cash flow with a 163.38% OCF to PAT ratio, indicating efficient cash generation.
- Efficient working capital management, as shown by a cash conversion cycle of 21.46 days.
- Consistent free cash flow generation, although growth has moderated.
Balance Sheet
UnitedHealth Group Inc. has an adequate but tight balance sheet — leverage and liquidity warrant monitoring.
Capacity to fund growth, withstand downturns and return capital.
- UnitedHealth Group Inc.
- has an adequate but tight balance sheet — leverage and liquidity warrant monitoring.
- Balance sheet is functional but shows no standout strengths
- Tight short-term liquidity cushion